Screener
RxSight, Inc. RXST Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $33.74M+0.3% | $30.89M-18.5% | $32.61M-18.9% | $30.34M-14.1% | $33.64M-3.6% | ||
| $9.24M-9.6% | $9.47M-8.6% | $8.91M-3.3% | $9.06M+2.5% | $10.22M+23.2% | ||
| $30.42M+5.0% | $31.86M+11.2% | $27.7M-1.8% | $27.35M+6.8% | $28.98M+19.3% | ||
| $7.86M-7.0% | —— | —— | —— | $8.45M— | ||
| -$13.77M+1.7% | -$17.83M-67.0% | -$11.34M-31.4% | -$12.18M-32.0% | -$14M-68.0% | ||
| -40.8%+0.8pp | -57.7%-29.5pp | -34.8%-13.3pp | -40.1%-14.0pp | -41.6%-17.7pp | ||
| $3K-40.0% | $3K-50.0% | $5K0.0% | $4K-20.0% | $5K-16.7% | ||
| -$12.01M-2.2% | -$15.88M-94.3% | -$9.15M-54.4% | -$9.81M-55.0% | -$11.75M-93.9% | ||
| $88K+175% | $6K-66.7% | $5K-58.3% | $10K-23.1% | $32K+100% | ||
| -$12.1M-2.6% | -$15.88M-93.9% | -$9.15M-54.1% | -$9.82M-54.9% | -$11.79M-93.9% | ||
| -35.9%-0.8pp | -51.4%-29.8pp | -28.1%-13.3pp | -32.4%-14.4pp | -35%-17.6pp | ||
| -$0.290.0% | -$0.38-90.0% | -$0.22-46.7% | -$0.24-50.0% | -$0.29-81.2% | ||
| -$12.77M+3.4% | -$17M-71.7% | -$10.49M-29.2% | -$11.32M-39.9% | -$13.22M-75.7% | ||
| -37.9%+1.4pp | -55%-28.9pp | -32.2%-12.0pp | -37.3%-14.4pp | -39.3%-17.7pp | ||
| -$13.77M+1.7% | -$17.83M-67.0% | -$11.34M-31.4% | -$12.18M-32.0% | -$14M-68.0% |
FAQ
- What is RxSight, Inc.'s revenue?
- RxSight, Inc. (RXST) generated $127.6M in revenue over the trailing twelve months, down 13.2% year over year.
- Is RxSight, Inc. profitable?
- RxSight, Inc. is not currently profitable: it reported a net loss of $46.9M over the trailing twelve months, a -36.8% net margin.
- What are RxSight, Inc.'s profit margins?
- Gross margin is 77.0% and operating margin is -43.2%, with a -36.8% net margin.
- What is RxSight, Inc.'s earnings per share?
- RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.
- Where does RxSight, Inc.'s income statement data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
